| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | central nervous system development | MYCN ABL1 NKX6-2 MYCBP2 CIC GDPD5 TTBK2 PTPRZ1 AFDN RECK MRTFA CCDC14 PLXNA3 FLNA HNF1B XRN2 SAMD4B XRCC1 MED1 TFAP2C SHANK3 WDR47 SPTBN4 MSX1 TENM4 BBS7 CHRD IRS2 ATIC HYDIN SEZ6 | 5.41e-07 | 1197 | 200 | 31 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | ABL1 CIC GDPD5 TTBK2 AFDN DIAPH3 MRTFA CCDC14 PLXNA3 FLNA HNF1B XRN2 SAMD4B XRCC1 MED1 TFAP2C SHANK3 WDR47 MSX1 BBS7 CHRD IRS2 ATIC HYDIN SEZ6 | 3.24e-06 | 919 | 200 | 25 | GO:0060322 |
| GeneOntologyBiologicalProcess | brain development | ABL1 CIC GDPD5 TTBK2 AFDN MRTFA CCDC14 PLXNA3 FLNA HNF1B XRN2 SAMD4B XRCC1 MED1 TFAP2C SHANK3 WDR47 MSX1 BBS7 CHRD IRS2 ATIC HYDIN SEZ6 | 3.30e-06 | 859 | 200 | 24 | GO:0007420 |
| GeneOntologyBiologicalProcess | positive regulation of synapse structural plasticity | 3.57e-06 | 4 | 200 | 3 | GO:0051835 | |
| GeneOntologyBiologicalProcess | regulation of synapse structural plasticity | 4.00e-06 | 12 | 200 | 4 | GO:0051823 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SYNPO2 ABL1 MYCBP2 TTBK2 FMN1 CLTC PKD1 DIAPH3 SHANK1 PLXNA3 FLNA RASA1 PPP1R9A SHANK3 WDR47 SPTBN4 CEP295 | 5.24e-05 | 579 | 200 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 9.09e-05 | 187 | 200 | 9 | GO:0007156 | |
| Domain | NUT | 1.19e-05 | 5 | 200 | 3 | IPR024310 | |
| Domain | NUT_N | 1.19e-05 | 5 | 200 | 3 | IPR024309 | |
| Domain | NUT | 1.19e-05 | 5 | 200 | 3 | PF12881 | |
| Domain | PDZ | 2.14e-05 | 141 | 200 | 9 | PF00595 | |
| Domain | PDZ | 3.14e-05 | 148 | 200 | 9 | SM00228 | |
| Domain | - | 3.50e-05 | 150 | 200 | 9 | 2.30.42.10 | |
| Domain | PDZ | 3.68e-05 | 151 | 200 | 9 | PS50106 | |
| Domain | PDZ | 3.88e-05 | 152 | 200 | 9 | IPR001478 | |
| Domain | zf-3CxxC | 6.51e-05 | 8 | 200 | 3 | SM01328 | |
| Domain | Znf-3CxxC | 6.51e-05 | 8 | 200 | 3 | IPR027377 | |
| Domain | Lgl_C | 1.14e-04 | 2 | 200 | 2 | PF08596 | |
| Domain | UBN_middle_dom | 1.14e-04 | 2 | 200 | 2 | IPR026947 | |
| Domain | HUN | 1.14e-04 | 2 | 200 | 2 | PF08729 | |
| Domain | HRD | 1.14e-04 | 2 | 200 | 2 | IPR014840 | |
| Domain | Lgl_C_dom | 1.14e-04 | 2 | 200 | 2 | IPR013905 | |
| Domain | UBN_AB | 1.14e-04 | 2 | 200 | 2 | PF14075 | |
| Domain | Calpain_cysteine_protease | 4.04e-04 | 14 | 200 | 3 | IPR022684 | |
| Domain | Peptidase_C2 | 5.01e-04 | 15 | 200 | 3 | PF00648 | |
| Domain | CysPc | 5.01e-04 | 15 | 200 | 3 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 5.01e-04 | 15 | 200 | 3 | IPR001300 | |
| Domain | CALPAIN_CAT | 5.01e-04 | 15 | 200 | 3 | PS50203 | |
| Domain | LLGL | 6.75e-04 | 4 | 200 | 2 | PF08366 | |
| Domain | G2F | 6.75e-04 | 4 | 200 | 2 | PF07474 | |
| Domain | FERM_f0 | 6.75e-04 | 4 | 200 | 2 | PF16511 | |
| Domain | NIDOGEN_G2 | 6.75e-04 | 4 | 200 | 2 | PS50993 | |
| Domain | GFP | 6.75e-04 | 4 | 200 | 2 | IPR009017 | |
| Domain | Lethal2_giant | 6.75e-04 | 4 | 200 | 2 | IPR000664 | |
| Domain | FERM_f0 | 6.75e-04 | 4 | 200 | 2 | IPR032425 | |
| Domain | REJ | 6.75e-04 | 4 | 200 | 2 | PS51111 | |
| Domain | REJ_dom | 6.75e-04 | 4 | 200 | 2 | IPR014010 | |
| Domain | G2_nidogen/fibulin_G2F | 6.75e-04 | 4 | 200 | 2 | IPR006605 | |
| Domain | LLGL2 | 6.75e-04 | 4 | 200 | 2 | IPR013577 | |
| Domain | Abhydrolase_6 | 1.12e-03 | 5 | 200 | 2 | PF12697 | |
| Domain | Gal_Lectin | 1.12e-03 | 5 | 200 | 2 | PF02140 | |
| Domain | Lectin_gal-bd_dom | 1.12e-03 | 5 | 200 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.12e-03 | 5 | 200 | 2 | PS50228 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCN MYCBP2 MAP4 ZFPM1 CIC UBN1 ZC3H4 CLTC DKC1 AFDN DMWD MRTFA FLNA XRN2 EP400 TCOF1 SAMD4B PHRF1 MED1 URGCP KANSL3 KMT2D IRS2 ZMYM3 SON | 5.98e-12 | 774 | 204 | 25 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABL1 MYCBP2 ZNF395 ZFPM1 EXTL3 ZNF236 STK11IP CIC RYR1 GDPD5 UBN1 PER2 PKD1 DMWD BAHCC1 PLXNA3 FLNA CRYBG2 EP400 TSNARE1 ZNF503 KANSL3 KMT2D SSU72 IRS2 ULK2 | 2.03e-09 | 1105 | 204 | 26 | 35748872 |
| Pubmed | ABCA12 TCP11L1 SUCLG1 ZC3H3 MYEF2 HMCN2 ZC3H4 SCO1 BAHCC1 ACTR8 EP400 TCOF1 TAF1C PHRF1 NTPCR ZBTB9 RNF213 SLC4A1 C1orf226 WDR6 CEP295 IRS2 CRYBG3 ZMYM3 CDH16 SON | 2.50e-09 | 1116 | 204 | 26 | 31753913 | |
| Pubmed | FRMPD4 TRO PER2 CLTC ADGRL3 EP400 STXBP5 PPP1R9A DENND11 WDR47 TENM4 ULK2 ZMYM3 SON | 1.52e-07 | 407 | 204 | 14 | 12693553 | |
| Pubmed | MYCBP2 MAP4 MPDZ UBN2 CLTC AFDN RPRD2 DIAPH3 FLNA EP400 LIMD1 TCOF1 MED1 KMT2D WDR6 NAA30 | 1.84e-07 | 549 | 204 | 16 | 38280479 | |
| Pubmed | ELP5 MYCBP2 PSMD4 CIC PTPRZ1 CLTC PYCR1 PPME1 DMWD CCDC14 VRK2 PPP1R9A RNF213 XRCC1 KMT2D C1orf226 FAM171A2 SSU72 EIF2AK4 CRYBG3 TNS1 SNTB1 | 2.80e-07 | 1049 | 204 | 22 | 27880917 | |
| Pubmed | MAP4 ZC3H4 DKC1 AFDN RPRD2 MRTFA FLNA XRN2 TCOF1 SAMD4B TOPBP1 MED1 USP5 IRS2 SON | 3.37e-07 | 503 | 204 | 15 | 16964243 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF395 UBN2 CIC UBN1 DKC1 RPRD2 CASP8AP2 XRN2 VRK2 ACTR8 EP400 TCOF1 BAZ2B TAF1C PHRF1 TOPBP1 XRCC1 MED1 TFAP2C KANSL3 KMT2D PTRH2 ZMYM3 SON | 7.10e-07 | 1294 | 204 | 24 | 30804502 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ENDOD1 MYCBP2 MAP4 VPS13C ZNF236 UBN2 TASOR2 SCP2 RPRD2 MMP16 RECK NSUN5P1 RASA1 LIMD1 EPB41L4B STXBP5L SOBP TSNARE1 PPP1R9A SAMD4B RNF213 FAM117B KANSL3 SPTBN4 EIF2AK4 GLIS1 | 7.33e-07 | 1489 | 204 | 26 | 28611215 |
| Pubmed | 8.58e-07 | 222 | 204 | 10 | 37071664 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP4 UBN2 CIC TASOR2 UBN1 ZC3H4 CLTC DKC1 AFDN RPRD2 FLNA XRN2 EP400 BAZ2B NTPCR TOPBP1 ZBTB9 XRCC1 MED1 SON | 1.01e-06 | 954 | 204 | 20 | 36373674 |
| Pubmed | MYCN PSMD4 CIC MYEF2 AFAP1L1 UBN1 RPRD2 MMP16 CCDC14 COL4A4 TAF1C SAMD4B XRCC1 SHANK3 URGCP SEZ6 | 3.57e-06 | 689 | 204 | 16 | 36543142 | |
| Pubmed | 3.65e-06 | 153 | 204 | 8 | 10718198 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYCBP2 PSMD4 TASOR2 DLGAP3 FBLN2 PIAS3 PYCR1 RPRD2 SHANK1 FLNA PLEKHA4 SHANK3 SPTBN4 CHRD | 6.45e-06 | 560 | 204 | 14 | 21653829 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYCBP2 MAP4 UBN2 ZC3H4 DKC1 DIAPH3 NRDE2 FLNA LIMD1 EPB41L4B TAF1C MED1 SYTL4 WDR6 NAA30 SON | 6.64e-06 | 724 | 204 | 16 | 36232890 |
| Pubmed | HDAC9 SYNPO2 PSMD4 EXTL3 CIC PIAS3 CLTC SHANK1 CCDC14 CASP8AP2 FLNA VRK2 TNS1 | 6.78e-06 | 486 | 204 | 13 | 20936779 | |
| Pubmed | MYCBP2 CIC DIAPH3 MRTFA CASP8AP2 FLNA ZBTB9 KMT2D WDR6 IRS2 CRYBG3 ZMYM3 | 7.62e-06 | 418 | 204 | 12 | 34709266 | |
| Pubmed | MYCBP2 VPS13C MPDZ AFAP1L1 RPRD2 VRK2 EP400 RNF149 RNF213 XRCC1 ZNF503 SYTL4 WDR6 BBS7 CEP295 ATIC | 7.75e-06 | 733 | 204 | 16 | 34672954 | |
| Pubmed | MYCBP2 MAP4 MYEF2 TASOR2 CLTC AFDN FLNA XRN2 TCOF1 PHRF1 USP5 WDR6 ATIC ZMYM3 SON | 8.24e-06 | 653 | 204 | 15 | 22586326 | |
| Pubmed | MYCBP2 MAP4 UBN2 CIC CLTC SCP2 PPME1 FLNA XRN2 EP400 BAZ2B NTPCR ZBTB9 XRCC1 MED1 ZNF503 KANSL3 KMT2D ATIC ZMYM3 | 8.83e-06 | 1103 | 204 | 20 | 34189442 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SYNPO2 TRO CIC TASOR2 UBN1 PIAS3 CLTC ADGRL3 MRTFA EP400 TCOF1 SON | 1.01e-05 | 430 | 204 | 12 | 35044719 |
| Pubmed | FRMPD4 MYCBP2 MAP4 DGKG PSMD4 SUCLG1 MYEF2 DLGAP3 CLTC AFDN ADGRL3 SHANK1 FLNA STXBP5L SHANK3 WDR47 TENM4 FAM171A2 PRKCG CRYBG3 | 1.40e-05 | 1139 | 204 | 20 | 36417873 | |
| Pubmed | Analysis of candidate genes on chromosome 2 in oral cleft case-parent trios from three populations. | 1.63e-05 | 9 | 204 | 3 | 16953426 | |
| Pubmed | VPS13C MYEF2 MAST4 ZC3H4 RPRD2 CASP8AP2 EP400 PITRM1 PHRF1 TOPBP1 URGCP KANSL3 EIF2AK4 | 1.66e-05 | 529 | 204 | 13 | 14621295 | |
| Pubmed | 2.31e-05 | 197 | 204 | 8 | 36604605 | ||
| Pubmed | HDAC9 MYCBP2 PSMD4 EXTL3 PIAS3 CLTC PKD1 PPME1 AFDN RECK SHANK1 XRN2 ACTR8 TCOF1 TAF1C ZBTB47 CAMK1 WDR47 SPTBN4 ATIC REPS2 | 2.46e-05 | 1285 | 204 | 21 | 35914814 | |
| Pubmed | MAP4 MPDZ UBN2 CIC MYEF2 SPCS3 AFDN NRDE2 VRK2 TBC1D30 EP400 TAF1C PPP1R9A SAMD4B PHRF1 NTPCR TOPBP1 XRCC1 MED1 TFAP2C PTRH2 ZMYM3 SON | 2.61e-05 | 1497 | 204 | 23 | 31527615 | |
| Pubmed | 2.73e-05 | 329 | 204 | 10 | 17474147 | ||
| Pubmed | CIC MYEF2 RYR1 TTBK2 SPCS3 PYCR1 ROBO4 NTPCR MUC16 MED1 KMT2D BBS7 CEP295 IRS2 | 2.74e-05 | 638 | 204 | 14 | 31182584 | |
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.17e-05 | 11 | 204 | 3 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.17e-05 | 11 | 204 | 3 | 9731539 | |
| Pubmed | 3.20e-05 | 268 | 204 | 9 | 33640491 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C RYR1 MYO15B CLTC PKD1 CFAP47 TBC1D30 EPB41L4B BAZ2B PCDHB14 RNF213 AMER3 CHRD CEP295 ATIC | 3.31e-05 | 736 | 204 | 15 | 29676528 |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 26399641 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 1571536 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 9537506 | ||
| Pubmed | Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice. | 3.42e-05 | 2 | 204 | 2 | 33402706 | |
| Pubmed | Identification of TopBP1 as a c-Abl-interacting protein and a repressor for c-Abl expression. | 3.42e-05 | 2 | 204 | 2 | 15961388 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 18427551 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 7987396 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 29742505 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 38214412 | ||
| Pubmed | The RECK tumor-suppressor protein binds and stabilizes ADAMTS10. | 3.42e-05 | 2 | 204 | 2 | 30287421 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 18826608 | ||
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 3.42e-05 | 2 | 204 | 2 | 24052634 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 19357112 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 34525172 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25229338 | ||
| Pubmed | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma. | 3.42e-05 | 2 | 204 | 2 | 33658627 | |
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 3.42e-05 | 2 | 204 | 2 | 16235097 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 30285846 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 24952595 | ||
| Pubmed | Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. | 3.42e-05 | 2 | 204 | 2 | 10679771 | |
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 3.42e-05 | 2 | 204 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 3.42e-05 | 2 | 204 | 2 | 12028435 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 23555306 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 18661361 | ||
| Pubmed | Identification and characterization of human LLGL4 gene and mouse Llgl4 gene in silico. | 3.42e-05 | 2 | 204 | 2 | 14767561 | |
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 3.42e-05 | 2 | 204 | 2 | 28674241 | |
| Pubmed | CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies. | 3.42e-05 | 2 | 204 | 2 | 29700887 | |
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 3.42e-05 | 2 | 204 | 2 | 35090027 | |
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 3.42e-05 | 2 | 204 | 2 | 32035013 | |
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 3.42e-05 | 2 | 204 | 2 | 17216251 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 35369551 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 3.42e-05 | 2 | 204 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 3.42e-05 | 2 | 204 | 2 | 16895672 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 30407212 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 12768082 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 3.42e-05 | 2 | 204 | 2 | 20029656 | |
| Pubmed | Treacle and TOPBP1 control replication stress response in the nucleolus. | 3.42e-05 | 2 | 204 | 2 | 34100862 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 3.42e-05 | 2 | 204 | 2 | 15280517 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15880327 | ||
| Pubmed | Regulation of kidney-specific Ksp-cadherin gene promoter by hepatocyte nuclear factor-1beta. | 3.42e-05 | 2 | 204 | 2 | 12217876 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 3.42e-05 | 2 | 204 | 2 | 25083577 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 20847057 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 32232700 | ||
| Pubmed | 3.64e-05 | 210 | 204 | 8 | 16537572 | ||
| Pubmed | ENDOD1 PSMD4 ZNF236 DIPK2A UBN1 CLTC PPME1 DKC1 DIAPH3 FLNA PITRM1 CENPO MED1 TFAP2C ARMC5 MCM9 PTRH2 EIF2AK4 ATIC ULK2 CAPN15 | 3.91e-05 | 1327 | 204 | 21 | 32694731 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UBN2 CIC UBN1 CLTC DIAPH3 CASP8AP2 XRN2 EP400 TCOF1 TOPBP1 KANSL3 CRYBG3 ZMYM3 | 4.93e-05 | 588 | 204 | 13 | 38580884 |
| Pubmed | MYCBP2 PSG3 MAST4 PIAS3 PKD1 AFDN ERVV-1 DIAPH3 FLNA LIMD1 USP5 KMT2D SON | 5.19e-05 | 591 | 204 | 13 | 15231748 | |
| Pubmed | 5.45e-05 | 13 | 204 | 3 | 12682087 | ||
| Pubmed | MYCBP2 MPDZ UBN2 MYEF2 DLGAP3 ZC3H4 CLTC AFDN SHANK1 TCOF1 PPP1R9A SHANK3 WDR47 SPTBN4 FAM171A2 PRKCG TNS1 | 5.94e-05 | 963 | 204 | 17 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MPDZ PSMD4 DLGAP3 SCO1 PYCR1 AFDN DIAPH3 PIPSL SLC27A3 FLNA PITRM1 TCOF1 USP5 WDR6 PTRH2 IRS2 SNTB1 | 6.82e-05 | 974 | 204 | 17 | 28675297 |
| Pubmed | 7.68e-05 | 449 | 204 | 11 | 31732153 | ||
| Pubmed | 9.82e-05 | 41 | 204 | 4 | 18951430 | ||
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 12388743 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.02e-04 | 3 | 204 | 2 | 27576055 | |
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 20047963 | ||
| Pubmed | A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers. | 1.02e-04 | 3 | 204 | 2 | 24522496 | |
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 32160132 | ||
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 7962065 | ||
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 28704582 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.02e-04 | 3 | 204 | 2 | 30647093 | |
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 11509555 | ||
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 26554816 | ||
| Pubmed | 1.02e-04 | 3 | 204 | 2 | 9620695 | ||
| Pubmed | Long days enhance recognition memory and increase insulin-like growth factor 2 in the hippocampus. | 1.02e-04 | 3 | 204 | 2 | 28634329 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 9.31e-05 | 316 | 204 | 8 | chr3p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG3 GGN CIC RYR1 ZC3H4 ERVV-1 DMWD SHANK1 ERVV-2 SAMD4B PLEKHA4 XRCC1 SPTBN4 PRKCG SLC7A10 | 3.15e-04 | 1192 | 204 | 15 | chr19q13 |
| GeneFamily | PDZ domain containing | 1.44e-06 | 152 | 129 | 9 | 1220 | |
| GeneFamily | Zinc fingers 3CxxC-type|Receptor transporter proteins | 1.94e-05 | 8 | 129 | 3 | 137 | |
| GeneFamily | Fibulins | 1.94e-05 | 8 | 129 | 3 | 556 | |
| GeneFamily | Beta-gamma crystallin domain containing | 1.51e-04 | 3 | 129 | 2 | 1360 | |
| GeneFamily | C2 domain containing|Calpains | 1.52e-04 | 15 | 129 | 3 | 975 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.21e-04 | 181 | 129 | 7 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.97e-04 | 206 | 129 | 7 | 682 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.10e-03 | 41 | 129 | 3 | 1298 | |
| GeneFamily | Sterile alpha motif domain containing | 3.63e-03 | 88 | 129 | 4 | 760 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | MYCN TCP11L1 DGKG ZNF395 ZFPM1 ITGA2B AFAP1L1 CAPN5 DIAPH3 BAHCC1 ROBO4 STXBP5 PPP1R9A CAMK1 SHANK3 TNS1 | 2.60e-06 | 423 | 199 | 16 | GSM399454_500 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MPDZ MAST4 AFDN ADGRL3 ROBO4 BAZ2B PPP1R9A RNF213 HMCN1 ZNF518B SON | 2.34e-09 | 200 | 204 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.28e-09 | 158 | 204 | 10 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | GALNT15 SYNPO2 FBLN2 HMCN2 MMP16 ADGRL3 COL4A4 SOBP CCDC80 TENM4 | 1.74e-08 | 188 | 204 | 10 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | AFAP1L1 MAST4 AFDN MMP16 ADGRL3 BAZ2B PPP1R9A SHANK3 THBD HMCN1 | 2.35e-08 | 194 | 204 | 10 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.38e-08 | 165 | 204 | 9 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.87e-07 | 184 | 204 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.24e-07 | 188 | 204 | 9 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-07 | 193 | 204 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.06e-07 | 155 | 204 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-06 | 173 | 204 | 8 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 177 | 204 | 8 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.87e-06 | 180 | 204 | 8 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.87e-06 | 180 | 204 | 8 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.87e-06 | 180 | 204 | 8 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-06 | 180 | 204 | 8 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-06 | 128 | 204 | 7 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-06 | 185 | 204 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-06 | 186 | 204 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-06 | 188 | 204 | 8 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-06 | 190 | 204 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 192 | 204 | 8 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 193 | 204 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-06 | 193 | 204 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 193 | 204 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 193 | 204 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.38e-06 | 195 | 204 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 196 | 204 | 8 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.65e-06 | 197 | 204 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.08e-06 | 200 | 204 | 8 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.88e-06 | 153 | 204 | 7 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-05 | 163 | 204 | 7 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 168 | 204 | 7 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 173 | 204 | 7 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 173 | 204 | 7 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 1.59e-05 | 174 | 204 | 7 | 6d9bdf4d28ff8ebb66ffd1ccdd6a4fe9440a83f3 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.59e-05 | 174 | 204 | 7 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 175 | 204 | 7 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 175 | 204 | 7 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 176 | 204 | 7 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP|lymph-node_spleen / Manually curated celltypes from each tissue | 1.71e-05 | 176 | 204 | 7 | 23a8ec42ebd42c539865a12d09773af90f3f8848 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 176 | 204 | 7 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 177 | 204 | 7 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.98e-05 | 180 | 204 | 7 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.01e-05 | 121 | 204 | 6 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 181 | 204 | 7 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 182 | 204 | 7 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 2.20e-05 | 183 | 204 | 7 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-05 | 183 | 204 | 7 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 184 | 204 | 7 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-05 | 185 | 204 | 7 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.36e-05 | 185 | 204 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.44e-05 | 186 | 204 | 7 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.44e-05 | 186 | 204 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-05 | 187 | 204 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-05 | 188 | 204 | 7 | 5d166d9e71632edd059ff0a9f66f8763f259d40a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 188 | 204 | 7 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.71e-05 | 189 | 204 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.71e-05 | 189 | 204 | 7 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-05 | 190 | 204 | 7 | 33d1b0a38267270e87702ba5794f07233acf4955 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 190 | 204 | 7 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-05 | 190 | 204 | 7 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 190 | 204 | 7 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-05 | 190 | 204 | 7 | ee39fb88f31d2d65b5d3e7416db68f5df07f6637 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-05 | 190 | 204 | 7 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 190 | 204 | 7 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-05 | 191 | 204 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.89e-05 | 191 | 204 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-05 | 191 | 204 | 7 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 192 | 204 | 7 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 192 | 204 | 7 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | PND03-Epithelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-05 | 192 | 204 | 7 | d8c23693f690d4d568585537bbfedda05d505b3d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 192 | 204 | 7 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 193 | 204 | 7 | 5dfa69a680a0859900141c40a446d217aaa747d3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 193 | 204 | 7 | ebea35704ac5d21e947ae094313cf2a5205e7014 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-05 | 193 | 204 | 7 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-05 | 193 | 204 | 7 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.09e-05 | 193 | 204 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.09e-05 | 193 | 204 | 7 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.20e-05 | 194 | 204 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-05 | 194 | 204 | 7 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-05 | 194 | 204 | 7 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.20e-05 | 194 | 204 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 194 | 204 | 7 | 23f2a627226aaed468c55adc42ab22e051dfe7fe | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-05 | 195 | 204 | 7 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.30e-05 | 195 | 204 | 7 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-05 | 195 | 204 | 7 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.30e-05 | 195 | 204 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.30e-05 | 195 | 204 | 7 | ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 196 | 204 | 7 | d74e899cc120146dded3a20716e22c7aca4f074a | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 198 | 204 | 7 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 198 | 204 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.64e-05 | 198 | 204 | 7 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 198 | 204 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-05 | 199 | 204 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.76e-05 | 199 | 204 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| Disease | Alport syndrome, recessive type | 4.35e-05 | 2 | 195 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 4.35e-05 | 2 | 195 | 2 | C2931253 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 4.35e-05 | 2 | 195 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 4.35e-05 | 2 | 195 | 2 | C0403440 | |
| Disease | benign familial hematuria (is_implicated_in) | 4.35e-05 | 2 | 195 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 4.35e-05 | 2 | 195 | 2 | C4746745 | |
| Disease | Benign familial hematuria | 4.35e-05 | 2 | 195 | 2 | cv:C0241908 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 1.30e-04 | 3 | 195 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 1.30e-04 | 3 | 195 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.30e-04 | 3 | 195 | 2 | cv:CN076135 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.55e-04 | 19 | 195 | 3 | EFO_0004630, HP_0002140 | |
| Disease | platelet endothelial aggregation receptor 1 measurement | 2.58e-04 | 4 | 195 | 2 | EFO_0801886 | |
| Disease | Hematuria, Benign Familial | 2.58e-04 | 4 | 195 | 2 | C0241908 | |
| Disease | Alport Syndrome | 2.58e-04 | 4 | 195 | 2 | C1567741 | |
| Disease | Malignant Cystosarcoma Phyllodes | 4.29e-04 | 5 | 195 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 4.29e-04 | 5 | 195 | 2 | C0010701 | |
| Disease | Alport Syndrome, X-Linked | 4.29e-04 | 5 | 195 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 4.29e-04 | 5 | 195 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 4.29e-04 | 5 | 195 | 2 | C1567744 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 4.57e-04 | 23 | 195 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | mean platelet volume | HDAC9 ENDOD1 ABO ACOX1 ITGA2B MAST4 UBN1 MRTFA FGD3 CCDC117 PCDHGB5 STXBP5 SHANK3 SYTL4 MCM9 IRS2 ULK2 | 4.64e-04 | 1020 | 195 | 17 | EFO_0004584 |
| Disease | obsolete_red blood cell distribution width | ABL1 ABO ZFPM1 MAST4 ZC3H4 DKC1 AFDN DCAF12 CCDC117 XRN2 EP400 BAZ2B NTRK1 SHBG CENPO MON1A SLC4A1 IRS2 EIF2AK4 NUTM2F | 6.40e-04 | 1347 | 195 | 20 | EFO_0005192 |
| Disease | hypertensive nephropathy | 6.40e-04 | 6 | 195 | 2 | C0848548 | |
| Disease | total blood protein measurement | 8.60e-04 | 449 | 195 | 10 | EFO_0004536 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.01e-03 | 30 | 195 | 3 | EFO_0004629, HP_0002140 | |
| Disease | triacylglycerol 58:10 measurement | 1.46e-03 | 34 | 195 | 3 | EFO_0010437 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.46e-03 | 34 | 195 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.46e-03 | 34 | 195 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.46e-03 | 34 | 195 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.46e-03 | 34 | 195 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.46e-03 | 34 | 195 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.46e-03 | 34 | 195 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.46e-03 | 34 | 195 | 3 | C0087012 | |
| Disease | CCL2 measurement | 1.53e-03 | 126 | 195 | 5 | EFO_0004749 | |
| Disease | malignant epithelial tumor of ovary | 1.59e-03 | 35 | 195 | 3 | MONDO_0018364 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.59e-03 | 35 | 195 | 3 | C0752122 | |
| Disease | endometrial endometrioid carcinoma | 2.30e-03 | 11 | 195 | 2 | EFO_1001514 | |
| Disease | eye measurement, sun exposure measurement | 2.30e-03 | 11 | 195 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | Inherited neuropathies | 2.35e-03 | 40 | 195 | 3 | C0598589 | |
| Disease | Profound Mental Retardation | 2.36e-03 | 139 | 195 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.36e-03 | 139 | 195 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.36e-03 | 139 | 195 | 5 | C0917816 | |
| Disease | epilepsy | 2.52e-03 | 41 | 195 | 3 | EFO_0000474 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.70e-03 | 42 | 195 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | collagen disease (implicated_via_orthology) | 2.75e-03 | 12 | 195 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.75e-03 | 12 | 195 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | phenylacetylglutamine measurement | 2.75e-03 | 12 | 195 | 2 | EFO_0021013 | |
| Disease | Intellectual Disability | 3.05e-03 | 447 | 195 | 9 | C3714756 | |
| Disease | cognitive function measurement | GALNT15 SYNPO2 FRMPD4 MAP4 DIPK2A SPCS3 MAST4 FMN1 DIAPH3 MRTFA VRK2 TSNARE1 ZBTB9 SHANK3 THBD KMT2D TENM4 ATIC HYDIN | 3.18e-03 | 1434 | 195 | 19 | EFO_0008354 |
| Disease | osteoarthritis, hip | 3.29e-03 | 92 | 195 | 4 | EFO_1000786 | |
| Disease | albuminuria | 3.55e-03 | 94 | 195 | 4 | EFO_0004285 | |
| Disease | triacylglycerol 48:4 measurement | 3.75e-03 | 14 | 195 | 2 | EFO_0010407 | |
| Disease | myopathy (implicated_via_orthology) | 3.95e-03 | 48 | 195 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | reticulocyte count | TSPAN15 ZCCHC24 ENDOD1 ABO ZFPM1 ZC3H4 PKD1 DCAF12 SOWAHD PLEKHA4 FAM117B SLC4A1 IRS2 EIF2AK4 TNS1 | 4.17e-03 | 1045 | 195 | 15 | EFO_0007986 |
| Disease | delta-6 desaturase measurement | 4.31e-03 | 15 | 195 | 2 | EFO_0007765 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 4.31e-03 | 15 | 195 | 2 | EFO_0004791, HP_0002140 | |
| Disease | reticulocyte measurement | TSPAN15 ZCCHC24 ENDOD1 ZFPM1 ZC3H4 AFDN DCAF12 FLNA SOWAHD PLEKHA4 SLC4A1 IRS2 EIF2AK4 TNS1 SLC7A10 | 4.47e-03 | 1053 | 195 | 15 | EFO_0010700 |
| Disease | Psychotic Disorders | 4.59e-03 | 101 | 195 | 4 | C0033975 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.22e-03 | 53 | 195 | 3 | C4707243 | |
| Disease | Acute Cerebrovascular Accidents | 5.50e-03 | 54 | 195 | 3 | C0751956 | |
| Disease | Metastatic melanoma | 5.50e-03 | 54 | 195 | 3 | C0278883 | |
| Disease | retinopathy | 5.54e-03 | 17 | 195 | 2 | EFO_0003839 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 5.54e-03 | 17 | 195 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | thrombomodulin measurement | 5.54e-03 | 17 | 195 | 2 | EFO_0007774 | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 5.54e-03 | 17 | 195 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | von Willebrand factor measurement | 6.09e-03 | 56 | 195 | 3 | EFO_0004629 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPGTTGLLAGESKAL | 571 | Q8N944 | |
| LGGDIHSGTALPTSK | 536 | P55196 | |
| GGAGLQPLASPSHIT | 246 | Q96L91 | |
| SQAGAVHGALGSKPP | 1681 | Q96L91 | |
| GPTFVPSVGHLADKG | 391 | Q9P281 | |
| GLTTEPIHKESGPGE | 316 | Q8IWZ6 | |
| HGVNPSVSGLSIPGI | 111 | Q8IWD4 | |
| PAGLLPHLSGLEAGA | 121 | Q92754 | |
| GVEILTPLFGTLHPG | 221 | P16442 | |
| PAGSPLLVGVGVSHS | 256 | P07357 | |
| NPGPSEISHVIGDKG | 941 | Q01955 | |
| PGSEASGPHLTGLEL | 746 | Q68DQ2 | |
| TGDLIKSDPSGHLTG | 886 | Q9P2K8 | |
| GGTEGHSPSGILEKI | 206 | P02730 | |
| SPKGVLEHSGSVGLA | 61 | Q9NS82 | |
| LNIHPGPGGSLTAVL | 191 | Q9H981 | |
| GHITSLLGPNGAGKT | 1371 | Q86UK0 | |
| GLGTLGTPTALAAHP | 91 | Q9UIF8 | |
| PSRGSEEHLKSGPGP | 31 | Q8WXI3 | |
| PPEGLDSGSGKAHLR | 276 | Q86XJ0 | |
| TPPEGSSKGPAHLVT | 1431 | Q9HAR2 | |
| GPGSSTKGPVLHDQD | 76 | Q96L96 | |
| KGTKGASGLHDVGPP | 1186 | P53420 | |
| GGLGPLVSLASHPKR | 281 | Q96C12 | |
| FGSGIPEGQHKSVPL | 71 | B6SEH9 | |
| SSGLSLGKEGPLVHV | 216 | P51793 | |
| VHVLGAAGLKDSPTG | 521 | O15484 | |
| PLPPSKEGGTGHSAL | 561 | Q9NSV4 | |
| KGPSLSSGLSLPVHP | 1386 | Q9UKL3 | |
| PGQVLSSGRHTGPAK | 56 | Q49A88 | |
| SRSNSLPHPAGGGKA | 491 | Q09019 | |
| LHGGPKGSRSPEESG | 161 | Q9H324 | |
| GSHGGRKVPLVSPDS | 31 | Q76M96 | |
| GPVSGGHINPAITLA | 61 | P55064 | |
| GGAHRGLSIPGPLTS | 191 | Q6P387 | |
| LLSSHIPLKGIEPGS | 691 | P20936 | |
| TVHPPPSTGLDGAKL | 276 | O95980 | |
| GELPVGPLNKRSTHG | 141 | Q68DA7 | |
| KSGSEGPVLLLLHGG | 71 | Q9Y570 | |
| AGTALSPSGHTKLLP | 296 | P32322 | |
| GLGHSKEAAAPAPIG | 71 | Q96IU4 | |
| KGTHSPPLTPEVAGL | 1066 | O75808 | |
| PGVSAKTAPLSTHPG | 11841 | Q8WXI7 | |
| PRLSGSNHSGSPKLG | 96 | Q9Y278 | |
| LSPTEGKGSGLQGHI | 476 | P04629 | |
| TPSSKPTLLANGGHG | 76 | P27816 | |
| DLGTGPKLSPTSLVH | 376 | Q9UGP4 | |
| KGPSSEPLHGQPGVA | 1286 | Q8NDA2 | |
| LSGSGGPPALNHAVL | 306 | P27539 | |
| PRPSFSGKLHNTGLG | 501 | Q8N3T1 | |
| GTPPAGLAADSHVKI | 41 | O94919 | |
| FGSGIPEGQHKSVPL | 71 | B6SEH8 | |
| TGPEGVTHAPSLGKA | 351 | P98095 | |
| GVGTHLTSLALPGKA | 646 | O15055 | |
| GPSGVLDVKPGSHVV | 1131 | P51805 | |
| GAGHPATKLPPDSLG | 386 | Q8IX07 | |
| VKDGSILSHPALPGT | 451 | Q9H7Z3 | |
| HGSLAPLGPSRGKGV | 756 | Q9P1Y6 | |
| PTLGHFLLGPDGEKV | 591 | Q0VF49 | |
| AKHLGVSGASLGVPL | 361 | A0A1B0GTW7 | |
| FLTGPPGVGKTTLIH | 6 | Q9BSD7 | |
| PVGPRGGGSHTKTLI | 586 | Q8WTR4 | |
| TKHPGKRLGSGPDGE | 591 | P05129 | |
| SPDIGPTGELSGSLK | 56 | Q5JSP0 | |
| TPGLGHKESALAPTA | 466 | Q86UU5 | |
| GAGTPSPVRLHALAG | 56 | Q3KNT7 | |
| SDKVPLHASLPVAGG | 851 | P23471 | |
| VLTALDGGHPPLSGT | 211 | Q9Y5G0 | |
| DGGHPPLSGTTELRI | 216 | Q9Y5G0 | |
| NGKDGTGSHLVTVPP | 646 | A2A3N6 | |
| GHPPGFITDGNSKLV | 2011 | Q7Z442 | |
| HPLTSSDKVLILPGG | 2816 | Q96RW7 | |
| TGEGGPVATLSKPSL | 186 | Q86Y26 | |
| ALAGGPAPTEKTPHS | 1076 | Q86Y26 | |
| HLLTGNGTEVPLSGP | 216 | A8MVW0 | |
| TASHGELLTPVAGGP | 331 | Q14012 | |
| PGKLPGLFDVGHVTE | 236 | Q96JP2 | |
| PQGHEAETPGKTKGL | 456 | Q9UHM6 | |
| GHPVGSLDGLLSPEA | 996 | Q9Y4H2 | |
| SGDSHKEGTRGPPPL | 166 | Q86VX9 | |
| DGGSPPKSGTTLVLI | 216 | Q9Y5E9 | |
| SPPGDGSVSKGHANI | 66 | A8MW95 | |
| PSGPAPAHSLGDLKG | 566 | P81408 | |
| GTHPLLVLVNPKSGG | 431 | P49619 | |
| EIGTHKPLPGITVGD | 211 | Q15067 | |
| GIAIIIHGTPLSGKS | 2036 | Q4G0P3 | |
| VSTLGDPGPHGFLRK | 746 | Q9Y6W3 | |
| TKLFVAGGPLPSGLH | 431 | Q5T6F0 | |
| GPGVAKTGLKAHEPT | 776 | P21333 | |
| HLSKPVAPGSAPLGS | 21 | A1L170 | |
| PSLGKHLIPDASGKG | 1241 | Q14CM0 | |
| GTSGGLLHDPPSEIA | 376 | Q8NDZ4 | |
| KGVLHAGPGRGSSLP | 196 | A4D1U4 | |
| LLPTPDLTLKGSGHS | 521 | Q6P1L5 | |
| PVLPSEAKFLGSGTG | 621 | O43909 | |
| KSVLSGGPLPQGHEF | 96 | P35219 | |
| LGTKLSALLPHGAPG | 926 | Q8N1P7 | |
| RAGLGHISPEGPLSL | 51 | O95886 | |
| PASGLPHKEEAGKGS | 826 | P00519 | |
| PHKEEAGKGSALGTP | 831 | P00519 | |
| PPLLRKTDQDHGGTG | 61 | A8MV24 | |
| PKPGGAHSLALVTVP | 641 | Q9NTJ4 | |
| IRPSTLHGLAPKLGG | 1346 | O15021 | |
| GATPGGKPTAIHQLL | 816 | Q9P2N6 | |
| PLRPDGESKGGVLAH | 6 | Q9BU64 | |
| LHGPGPVGALSSLAQ | 171 | Q8TE02 | |
| GPAPHSAGAGLLRIS | 276 | Q6UY11 | |
| LEGHTPPLGGYKVTA | 916 | Q9UKV0 | |
| SSGLGLQPETHLPEG | 46 | Q8NBF1 | |
| GHSEIPTLPDGLLGL | 1431 | Q9C0D2 | |
| GLLDKHGKPTDSTPA | 396 | O60832 | |
| NGKDGTGSHLVTVPP | 161 | P55036 | |
| LAAPTGHPPTSGVEK | 981 | Q5VT52 | |
| IGKPLLGGPFSLTTH | 131 | O75880 | |
| AKGGGTHPLLVPYDT | 2896 | P21817 | |
| TDIGLEPGSGLKSPS | 666 | Q6ZTR5 | |
| SPHKSEGKGLLSPGA | 726 | Q9H329 | |
| SKHGLDVALPTAGPV | 406 | Q5SV97 | |
| VSGPSKDPDLASGHG | 686 | O75309 | |
| GKPGSSPITKHGLSS | 1151 | Q15648 | |
| ISPSHSRPPGGSDKL | 1191 | Q15648 | |
| KHGVVTSGPGGEDPL | 1311 | Q15648 | |
| TLVGPHGPLASGQLA | 276 | P98161 | |
| VKVSAPSGTGHLPGL | 411 | Q16557 | |
| SGGGLPPVSTLTNIH | 406 | P35680 | |
| SHLLLVGDPGTGKSQ | 346 | Q9NXL9 | |
| ALGLPGESPVKESHG | 611 | A1L443 | |
| ALGLPGESPVKESHG | 596 | Q5VZR2 | |
| SLLPHLKTGNSSPGI | 176 | Q96DX8 | |
| AESPTGLPSHKGELV | 486 | Q96C24 | |
| SGHQKPLPTVPGGLS | 456 | Q9NUJ3 | |
| LSLKLVHVAGPGPTG | 86 | Q8N1F8 | |
| LATRLVHSGPGKGSP | 376 | Q13884 | |
| TPPAVGLVHSGLLIG | 506 | P07204 | |
| APGLVAALHIVGGTP | 156 | Q9BVQ7 | |
| EGPQGAKSAHTLGPT | 1161 | Q13428 | |
| KAEVPGATGGDSPHL | 6 | Q9P2K5 | |
| QLPLGTPHGISDILG | 51 | Q9C056 | |
| TPHGISDILGRPVGA | 56 | Q9C056 | |
| SPRPLGHFSVGGLLK | 111 | P28360 | |
| GDKDLASPHLGLGSP | 546 | Q9H4M7 | |
| EKGATGISLSPHLPG | 336 | Q15572 | |
| TGKSTHGLAILGPEN | 1011 | Q5JRX3 | |
| GSGHLLALGTPENPS | 261 | P04278 | |
| VPNAGILPLVTGSGH | 151 | P61009 | |
| GILGKGLALSHSPTI | 2206 | O75592 | |
| SAPGSGGLTPLHLAA | 181 | A6NJG2 | |
| RGPHALGAPSLLLTG | 366 | P08514 | |
| GTTLNLDLGGKHSPI | 561 | P08514 | |
| PSGGLISKGHPLGAT | 346 | P22307 | |
| GKASRSLAQHIPGPG | 1071 | Q5T5C0 | |
| STGLPLLTSGHDGPE | 821 | Q969V6 | |
| TTPGKGGQTHLGLPV | 86 | P53597 | |
| GKASRSLAQHIPGPG | 1106 | Q9Y2K9 | |
| KPLALQPGRHTVSGG | 176 | Q8WZ75 | |
| SESPGPGGLASLGKH | 836 | Q9Y566 | |
| LAGGPALGLSVSSKP | 701 | Q8TED9 | |
| APHLVAGPLLGTVGK | 741 | Q96RK0 | |
| GKLHIIEVGTPPTGN | 226 | Q00610 | |
| GSEQGTVTAHLLGPP | 576 | Q9H2X0 | |
| PALPGSKGVLTSGHQ | 476 | Q9Y6X2 | |
| IGPGPADLIDKVTGH | 161 | Q9Y3E5 | |
| LLLPESKGGSSEPGT | 241 | Q63HN8 | |
| TLRPKHGGTTDVGEP | 591 | Q8TCY9 | |
| DSSPKEGAHGLVGVP | 66 | Q8NC42 | |
| SEHSVIKPPLGDSPG | 566 | O94967 | |
| SGDRPAVGHSGLKPL | 416 | Q8IXZ2 | |
| AVGHSGLKPLSGETP | 421 | Q8IXZ2 | |
| PKKPQDLAHTGISSG | 841 | Q6ZU65 | |
| DLRKAAHGPSPGSGK | 201 | Q96NA8 | |
| ERHKGASGPLVALPG | 206 | Q9UMS6 | |
| VLPEGPVGHSGKLFS | 581 | O75970 | |
| DLITLGSGIPPHGID | 426 | P51512 | |
| SEKLQHGRGPPTAGS | 131 | P04198 | |
| SGGPGTKPLRHQASL | 241 | Q8NFH8 | |
| LSPSGIGGVSPRHAL | 591 | Q5PRF9 | |
| LGPSGSTFIHPLTGK | 1086 | Q9BYB0 | |
| PTGHEGGTIQLKSPL | 156 | Q12816 | |
| GHAKPGTPALETLET | 536 | Q03431 | |
| GPGTHPAGISDLLAE | 246 | Q5K4L6 | |
| AAAGGKPSGHSLSPR | 571 | A7XYQ1 | |
| HSVTDGLLGPGAKPS | 266 | O95858 | |
| VGVSPDKLPGSLGHP | 361 | Q6IQ55 | |
| GILTPHALGSRNSPG | 436 | Q9H0D6 | |
| AIASPGSPSLGRHLG | 1291 | Q9HBL0 | |
| HPGPESSLPSGALSK | 381 | Q9H8N7 | |
| KPGPSEGDLAILGLS | 2621 | Q6N022 | |
| LAHGLSLEAPTVGKG | 16 | Q53EL9 | |
| KGPASGSTHGGEPLL | 2461 | Q9H254 | |
| SPVKLHLSLSLGSGG | 3331 | Q709C8 | |
| GHTGGKISPVPYEDL | 706 | Q9Y2I9 | |
| LGETSAGPGKSLPVF | 271 | Q9Y279 | |
| KHVSPAGAAVGIPLS | 266 | P31939 | |
| GLGPVSTLPSLHGKQ | 556 | Q9NNW5 | |
| SHTLAGDGVPAAPGL | 686 | Q9UFB7 | |
| SSGLGDPRLQKGHPT | 841 | Q9UPT8 | |
| AVHGPVKLGGTPPAD | 366 | Q96C00 | |
| SRPGSLGTSPTKHLG | 566 | Q8IYT8 | |
| PHGVALDPTKPGSLV | 376 | Q96F45 | |
| LTSGAGLLPGLGSHP | 16 | Q96NZ8 | |
| PLSSSPVEHEGVLKG | 141 | Q6ZMS4 | |
| LGKDHLPSSPGLLTV | 206 | A8MUA0 | |
| SLPGASQLHGKGPAV | 1116 | Q9NPG3 | |
| SHSGGSGDEAPKLPQ | 416 | P18887 | |
| QGLVSPSGGPHEITL | 1481 | Q9UL36 | |
| AELHKETTGPGTAGP | 1701 | Q5VWN6 | |
| QSGGAKVLPGHSVPL | 1416 | Q92547 | |
| GHPEVTTATGLLGQP | 526 | P18583 | |
| FGTGTHVKLPGPAPD | 36 | Q9NP77 | |
| GHGLLSGEYSKPVPE | 381 | P45974 | |
| HGIPLGPLDFSTKGQ | 316 | Q86Y07 | |
| KTGSPGPELLFHEGQ | 461 | Q14202 | |
| GSTVPLGQPGLSGHK | 16 | A6NP61 | |
| GLGHSTGTLQKPPND | 716 | Q9C0D4 | |
| GKGRPEQLGSPLHSS | 56 | Q8N2G6 | |
| SSGTHLGGLELKTPD | 2311 | O14686 | |
| PAGGESATVAAKGHP | 56 | Q147X3 | |
| DLSGLGAEPKTPGLS | 936 | Q9ULJ8 |